Description
Ipamorelin is a selective growth hormone secretagogue (GHS) peptide widely studied for its ability to stimulate the release of growth hormone via ghrelin receptor (GHS-R1a) activation. Unlike earlier GHRPs, Ipamorelin is noted for its high selectivity, minimal effects on cortisol and prolactin, and a clean research profile, making it a preferred model compound for investigating growth hormone signaling pathways.
Each 10 mg vial contains lyophilized Ipamorelin powder with verified purity of ≥98% (HPLC). This research-grade pentapeptide is supplied in a stable form designed for advanced laboratory and analytical applications.
Research applications include investigation of:
-
Pituitary growth hormone release mechanisms
-
Ghrelin receptor binding and signal transduction
-
Skeletal muscle growth and repair pathways
-
Energy metabolism and recovery models
-
Comparative studies of GHRPs and GH secretagogues
Mechanistic insights: Ipamorelin binds selectively to the ghrelin receptor, inducing a controlled release of endogenous growth hormone. This allows for precise research into endocrine modulation, anabolic signaling, and tissue repair without significant off-target hormonal effects. Studies frequently compare Ipamorelin with GHRP-2, GHRP-6, and hexarelin to evaluate receptor selectivity and physiological outcomes.
This material is supplied specifically for laboratory research use only (RUO) in the fields of endocrinology, metabolism, and growth hormone biology. Proper storage at –20 °C or below is recommended; when stored as directed, the peptide maintains stability for up to 24 months. Not for human or veterinary consumption.
